Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement (Q79756908)
Jump to navigation
Jump to search
scientific article published on 12 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement |
scientific article published on 12 February 2007 |
Statements
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement (English)
Menno V Huisman
Bengt I Eriksson
Ola E Dahl
Sylvia Haas
Ajay K Kakkar
Frank Misselwitz
Eva Muehlhofer
12 February 2007